Login
Navigate Fool.com
Will DGX beat
the market?

Quest Diagnostics

NYSE: DGX

Community Rating: 4 Stars: Favorite

58.40 -0.90 (-1.52%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.50
Previous Close $59.30
Daily Range $58.37 - $59.87
52-Week Range $50.46 - $64.10
Market Cap $8.4B
P/E Ratio 11.17
Dividend (Yield) $1.32 (2.2%)
Ex-Dividend Date
Dividend Pay Date
04/04/14
04/23/14
Volume 2,401,816
Average Daily Volume 2,693,638
Current FY EPS $4.04

How do you think DGX
will perform against the market?

Top DGX Bull/Bear Pitches

 

zycantodan (< 20)
Submitted March 7, 2011

Clean facilities and well-integrated IT systems from the patient side - you can schedule appointments online and find locations easily. This significantly cuts down on in-office wait time. All labeli … More

0 Replies Reply Report this Post
 

pickumnow (< 20)
Submitted May 23, 2008

Good growth potential in an area that is need of productivity and quality care solutions.

0 Replies Reply Report this Post

News & Commentary Rss Feed

Laboratory Service Providers Should Profit From This New Revenue Source

Legacy laboratory service providers such as Laboratory Corporation of America and Quest Diagnostics have found growth hard to come by recently. But a new revenue source may provide these "old school" medical diagnostics specialists with a surprisingly lucrative future.

January 2016 Options Now Available For Quest Diagnostics (DGX)

Better Buy: Laboratory Corp Vs. Quest Diagnostics

LabCorp (LH) and Quest Diagnostics (DGX) face off in the competitive lab services market. Since warmer weather boosts lab services volume, let's see if one is a better buy than the other.

Quest Diagnostics Incorporated (DGX) Ex-Dividend Date Scheduled for April 04, 2014

When Harsh Medicare Cuts Are Cause for Celebration

The Medicare cuts were big, but not as big as the market had feared, which is cause for celebration for Myriad.

3 Dividend Stocks for Next Quarter

GlaxoSmithKline (GSK), Merck (MRK), and Quest DIagnositcs (DGX) not only offer compelling dividend yields but also a strong history of shareholder-friendly returns next quarter.

Medicare Reimbursement Relief for Lab Testing, Maybe

DGX Crosses Above Key Moving Average Level

Plug Power leads fuel-cell stocks lower

1 Great Dividend You Can Buy Right Now

Shareholders in this diagnostics company have witnessed their dividend grow by 340% over the past decade, and that could be just the tip of the iceberg.

See More DGX News...

Sector

Healthcare

Industry

Healthcare Information Services

Quest Diagnostics (DGX) Description

A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health. Website: http://www.questdiagnostics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks